Regenxbio (RGNX) EBIT Margin (2014 - 2026)
Regenxbio (RGNX) posted quarterly EBIT Margin of 212.3% for Q4 2025, up 2984.0% year-over-year from 6.88% in Q4 2024, and down 20.44% quarter-over-quarter from 176.27% in Q3 2025.
Powered by 
Analysis
Regenxbio (RGNX) EBIT Margin (2014 - 2026) Analysis & Trends
Regenxbio's EBIT Margin history runs 12 years deep, the most recent figure standing at 212.3% for Q4 2025.
- In Q4 2025, EBIT Margin rose 2984.0% year-over-year to 212.3%; the TTM figure through Dec 2025 stood at 97.52% (up 18497.0% YoY), while the FY2025 annual figure was 103.16%, up 17688.0% from the prior year.
- EBIT Margin for Q4 2025 stood at 212.3%, down from 176.27% in the prior quarter.
- The five-year high for EBIT Margin was 78.66% in Q4 2021, with the low at 416.21% in Q1 2024.
- The 5-year median for EBIT Margin is 239.58% (2021), against an average of 230.5%.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin plunged 26297 bps in 2022, then surged 43014 bps in 2025.
- Regenxbio's EBIT Margin stood at 78.66% in 2021, then sank by 334 bps to 184.31% in 2022, then tumbled by 56 bps to 287.68% in 2023, then grew by 16 bps to 242.14% in 2024, then rose by 12 bps to 212.3% in 2025.
- Business Quant data shows RGNX's EBIT Margin at 212.3% in Q4 2025, 176.27% in Q3 2025, and 296.26% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | 27.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.09% |
| Dec 31, 2025 | -189.99% |
| Sep 30, 2025 | -176.27% |
| Jun 30, 2025 | -296.26% |
| Mar 31, 2025 | 13.62% |
| Dec 31, 2024 | -242.14% |
| Sep 30, 2024 | -256.55% |
| Jun 30, 2024 | -251.34% |
| Mar 31, 2024 | -408.80% |
| Dec 31, 2023 | -287.68% |
| Sep 30, 2023 | -224.67% |
| Jun 30, 2023 | -365.96% |
| Mar 31, 2023 | -345.68% |
| Dec 31, 2022 | -184.31% |
| Sep 30, 2022 | -267.97% |
| Jun 30, 2022 | -191.53% |
| Mar 31, 2022 | -321.93% |
| Dec 31, 2021 | 78.66% |
| Sep 30, 2021 | -186.36% |
| Jun 30, 2021 | -237.01% |